ESC 365 - Assistant Professor Jeong Cheon Choe

Speaker illustration

Assistant Professor Jeong Cheon Choe

Pusan National University Hospital, Pusan (Korea (Republic of))

Member of:

The long-term clinical benefit of early versus delayed invasive strategies in elderly patients with non-ST-segment elevation myocardial infarction who have undergone percutaneous coronary intervention

Event: ESC Congress 2024

Topic: Cardiovascular Disease in the Elderly

Session: Cardiovascular outcome studies in the elderly

Sex differences in clinical data and long-term outcomes of elderly patients with acute myocardial infarction presenting with cardiogenic shock undergoing percutaneous coronary intervention

Event: ESC Congress 2024

Topic: Cardiovascular Disease in the Elderly

Session: Elderly with cardiovascular disease: diagnostics and outcome

The impact of statin intensity on long-term outcomes in elderly patients with acute myocardial infarction who have undergone percutaneous coronary intervention

Event: ESC Congress 2023

Topic: Lipid-Lowering Agents

Session: Statins, bempedoic acid and ezetimibe: novel findings

Long-term outcomes of beta-blocker use in elderly patients without left ventricular systolic dysfunction after percutaneous coronary intervention for acute myocardial infarction

Event: ESC Congress 2023

Topic: Beta-Blockers

Session: Pharmacotherapy in myocardial infarction

Updated meta-analysis of biodegradable polymer drug-eluting stent versus second-generation durable polymer drug-eluting stent implantations

Event: ESC Congress 2019

Topic: Revascularisation

Session: Optimal treatment of coronary artery disease

The effect of initial pulse pressure on heart failure readmission in hypertensive octogenarian patients presenting acute myocardial infarction treated with percutaneous coronary intervention

Event: Heart Failure 2019

Topic: Hypertension, Other

Session: Hypertension

Sexual differences in heart failure with mid-range ejection fraction patients

Event: Heart Failure 2019

Topic: Heart Failure with Mid-Range Ejection Fraction (HFmrEF)

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

The effect of ejection fraction change during follow-up on outcomes in patients with heart failure with mid-range ejection fraction

Event: Heart Failure 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic Heart Failure – Epidemiology, Prognosis, Outcome

Prognosis of biodegradable polymer drug-eluting stents versus second-generation durable polymer drug-eluting stents in acute myocardial infarction patients following percutaneous coronary intervention

Event: ESC Congress 2018

Topic: Stents

Session: Outcome of coronary stenting up to 10 years

The impact of coronary artery disease on clinical outcomes in heart failure with mid-range ejection fraction patients

Event: Heart Failure 2018

Topic: Heart Failure with Mid-Range Ejection Fraction (HFmrEF)

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources